BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 13129606)

  • 1. Micromanipulation of the Chlamydia pneumoniae inclusion: implications for cloning and host-pathogen interactions.
    Gieffers J; Tamplin V; Maass M; Belland RJ; Caldwell HD
    FEMS Microbiol Lett; 2003 Sep; 226(1):45-9. PubMed ID: 13129606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and intracellular localization of putative Chlamydia pneumoniae effector proteins.
    Müller N; Sattelmacher F; Lugert R; Gross U
    Med Microbiol Immunol; 2008 Dec; 197(4):387-96. PubMed ID: 18449565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of a Mycoplasma group-specific PCR for monitoring decontamination of Mycoplasma-infected Chlamydia sp. strains.
    Ossewaarde JM; de Vries A; Bestebroer T; Angulo AF
    Appl Environ Microbiol; 1996 Feb; 62(2):328-31. PubMed ID: 8593037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent contamination of Chlamydia trachomatis and Chlamydia pneumoniae strains with mycoplasma. Biological relevance and selective eradication of mycoplasma from chlamydial cultures with mupirocin.
    Krausse-Opatz B; Dollmann P; Zeidler H; Kuipers JG; Köhler L
    Med Microbiol Immunol; 2000 Sep; 189(1):19-26. PubMed ID: 11034554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydial antigens colocalize within IncA-laden fibers extending from the inclusion membrane into the host cytosol.
    Brown WJ; Skeiky YA; Probst P; Rockey DD
    Infect Immun; 2002 Oct; 70(10):5860-4. PubMed ID: 12228318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic tests: Chlamydia trachomatis, Chlamydophila pneumoniae].
    Kishimoto T; Ando S; Ogawa M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():220-6. PubMed ID: 16111232
    [No Abstract]   [Full Text] [Related]  

  • 7. No evidence of involvement of Chlamydia pneumoniae in severe cerebrovascular atherosclerosis by means of quantitative real-time polymerase chain reaction.
    Apfalter P; Barousch W; Nehr M; Willinger B; Rotter M; Hirschl AM
    Stroke; 2004 Sep; 35(9):2024-8. PubMed ID: 15256684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycoplasma contamination of chlamydiae isolated from clinical specimens.
    Messmer TO; Black CM; Thacker WL
    APMIS; 1994 Oct; 102(10):793-6. PubMed ID: 7826610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flotillin-1 (Reggie-2) contributes to Chlamydia pneumoniae growth and is associated with bacterial inclusion.
    Korhonen JT; Puolakkainen M; Häivälä R; Penttilä T; Haveri A; Markkula E; Lahesmaa R
    Infect Immun; 2012 Mar; 80(3):1072-8. PubMed ID: 22215737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of Chlamydia pneumoniae clonal variants by a focus-forming assay.
    Gieffers J; Belland RJ; Whitmire W; Ouellette S; Crane D; Maass M; Byrne GI; Caldwell HD
    Infect Immun; 2002 Oct; 70(10):5827-34. PubMed ID: 12228314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of in vitro chlamydial cultures in low-oxygen atmospheres.
    Juul N; Jensen H; Hvid M; Christiansen G; Birkelund S
    J Bacteriol; 2007 Sep; 189(18):6723-6. PubMed ID: 17631631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingomyelin trafficking in Chlamydia pneumoniae-infected cells.
    Wolf K; Hackstadt T
    Cell Microbiol; 2001 Mar; 3(3):145-52. PubMed ID: 11260137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymerase chain reaction detection of Chlamydia pneumoniae in circulating white blood cells.
    Boman J; Gaydos CA
    J Infect Dis; 2000 Jun; 181 Suppl 3():S452-4. PubMed ID: 10839737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Widely used, commercially available Chlamydia pneumoniae antigen contaminated with mycoplasma.
    Verkooyen RP; Sijmons M; Fries E; Van Belkum A; Verbrugh HA
    J Med Microbiol; 1997 May; 46(5):419-24. PubMed ID: 9152039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host alpha-adducin is redistributed and localized to the inclusion membrane in chlamydia- and chlamydophila-infected cells.
    Chu HG; Weeks SK; Gilligan DM; Rockey DD
    Microbiology (Reading); 2008 Dec; 154(Pt 12):3848-3855. PubMed ID: 19047752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amalgamation of Chlamydia pneumoniae inclusions with lipid droplets in foam cells in human atherosclerotic plaque.
    Bobryshev YV; Killingsworth MC; Tran D; Lord R
    Virchows Arch; 2008 Jul; 453(1):69-77. PubMed ID: 18528704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of Chlamydia pneumoniae in atherosclerotic plaques of Australian subjects.
    Cochrane M; Kalle WH; Roffey P; Moriarty HT
    Pathology; 2002 Jun; 34(3):270-4. PubMed ID: 12109790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel method for isolation of Chlamydia pneumoniae by treatment with trypsin or EDTA.
    Kazuyama Y; Lee SM; Amamiya K; Taguchi F
    J Clin Microbiol; 1997 Jun; 35(6):1624-6. PubMed ID: 9163501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical bacterial pathogen infection in children with acute bronchiolitis in northeast Thailand.
    Pientong C; Ekalaksananan T; Teeratakulpisarn J; Tanuwattanachai S; Kongyingyoes B; Limwattananon C
    J Microbiol Immunol Infect; 2011 Apr; 44(2):95-100. PubMed ID: 21439510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of DNA chip scanning technology for automatic detection of Chlamydia trachomatis and Chlamydia pneumoniae inclusions.
    Bogdanov A; Endrész V; Urbán S; Lantos I; Deák J; Burián K; Önder K; Ayaydin F; Balázs P; Virok DP
    Antimicrob Agents Chemother; 2014; 58(1):405-13. PubMed ID: 24189259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.